Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 75,029	$ 2,208
Restricted cash	4,336	605
Marketable securities – at fair value	116,589	1,032
Accounts receivable, net	8,206	4,132
Inventories	40,985	11,202
Other current assets	4,705	6,679
Total Current Assets	249,850	25,858
Marketable securities – at fair value	1,941	0
Property and equipment, net	22,628	1,868
Capitalized website and internal-use software costs, net	13,716	0
Lease vehicles, net	1,596	173
Other assets	558	299
Total Assets	290,289	28,198
Current Liabilities:
Long-term debt, current	509	6,370
Floorplan notes payable	27,815	6,039
Accounts payable	6,352	6,283
Accrued transaction expenses	0	6,052
Accrued expenses	14,428	3,563
Accrued expenses – related party	0	5,082
Other current liabilities	754	256
Total Current Liabilities	49,858	33,645
Long-term debt, less current portion	12,206	2,999
Redeemable convertible preferred stock tranche obligation	0	2,832
Earnout shares liability	7,679	0
Other liabilities	744	1,959
Total Liabilities	76,778	41,435
Commitments and Contingencies (Note 15)	0	0
Stockholders’ Equity (Deficit):
Common stock, $0.0001 par value; 500,000,000 authorized shares, 113,996,401 and 58,621,042 shares issued and outstanding at December 31, 2021 and December 31, 2020	11	6
Additional paid-in capital	287,509	20,779
Accumulated deficit	(73,916)	(34,037)
Accumulated other comprehensive (loss) income	(93)	15
Total Stockholders’ Equity (Deficit)	213,511	(13,237)
Total Liabilities and Stockholders’ Equity (Deficit)	290,289	28,198
Merger warrants liability
Current Liabilities:
Merger warrants liability	$ 6,291	$ 0